Showing results (2451-2460 of 3,164) with videos related to
Sort By:
Pageof 317
Neuro-Oncology|September 11, 2019
MEK/MELK inhibition and blood-brain barrier deficiencies in atypical teratoid/rhabdoid tumorsMichaël H Meel, Miriam Guillén Navarro, Mark C de Gooijer, et al.Neuro-Oncology|August 18, 2019
Tumoricidal stem cell therapy enables killing in novel hybrid models of heterogeneous glioblastomaAndrew B Satterlee, Denise E Dunn, Donald C Lo, et al.Neuro-Oncology|November 20, 2018
Craniospinal irradiation as part of re-irradiation for children with recurrent intracranial ependymomaDerek S Tsang, Louise Murray, Vijay Ramaswamy, et al.Neuro-Oncology|February 9, 2021
Neurocognitive functioning and radiologic changes in primary CNS lymphoma patients: results from the HOVON 105/ALLG NHL 24 randomized controlled trialMatthijs van der Meulen, Linda Dirven, Esther J J Habets, et al.Neuro-Oncology|February 16, 2021
Integrated molecular analysis of adult sonic hedgehog (SHH)-activated medulloblastomas reveals two clinically relevant tumor subsets with VEGFA as potent prognostic indicatorAndrey Korshunov, Konstantin Okonechnikov, Damian Stichel, et al.Neuro-Oncology|February 16, 2017
Characteristics of H3 K27M-mutant gliomas in adultsDavid Meyronet, Maud Esteban-Mader, Charlotte Bonnet, et al.Neuro-Oncology|February 16, 2017
Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomasKhalil Abou-El-Ardat, Michael Seifert, Kerstin Becker, et al.Neuro-Oncology|February 17, 2017
O-(2-18F-fluoroethyl)-L-tyrosine PET for evaluation of brain metastasis recurrence after radiotherapy: an effectiveness and cost-effectiveness analysisAlexander Heinzel, Dirk Müller, Sareh Said Yekta-Michael, et al.Neuro-Oncology|February 17, 2017
Comparison of 2D (RANO) and volumetric methods for assessment of recurrent glioblastoma treated with bevacizumab-a report from the BELOB trialRenske Gahrmann, Martin van den Bent, Bronno van der Holt, et al.Neuro-Oncology|September 25, 2019
Cognitive and brain structural changes in long-term oligodendroglial tumor survivorsNuria Cayuela, Esteban Jaramillo-Jiménez, Estela Càmara, et al.Pageof 317